Floatz logo

Denosumab

Dense Breasts

Washington University School of Medicinemonoclonal_antibodyPhase 2Active
CCC
53/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
38/ 100
Competitive Position
95/ 100

Competitive context

2 Active assets in the Dense Breasts cohort.

Asset / SponsorPhaseRating
VITAMIN D
Washington University School of Medicine
Phase 2CCC
Calcium
Washington University School of Medicine
Phase 2CCC

Same molecule, other indications

Denosumab is also rated in:

metastatic carcinoma in the boneDormant
BBB
Indicative ·
79 / 100
View asset →
breast carcinomaDormant
BB
Indicative ·
70 / 100
View asset →
castration-resistant prostate carcinomaDormant
BB
Indicative ·
68 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →